Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 10-1996 | 07-1996 | 04-1996 | 01-1996 | |
| Assets | |||||
| Current Assets | |||||
| Inventories | 0 | N/A | N/A | N/A | 38,849 |
| Other current assets | 0 | 7,855 | 6,165 | 6,028 | 5,743 |
| TOTAL | $0 | $7,855 | $6,165 | $6,028 | $44,592 |
| Non-Current Assets | |||||
| PPE Net | N/A | 41,359 | 37,614 | 35,606 | 31,789 |
| Other Non-Current Assets | 0 | 4,422 | 4,532 | 4,519 | 4,211 |
| TOTAL | $N/A | $45,781 | $42,146 | $40,125 | $36,000 |
| Total Assets | $0 | $53,636 | $48,311 | $46,153 | $80,592 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 3,850 | 3,810 | 3,804 | 3,804 |
| Accounts payable and accrued liabilities | 0 | 19,993 | 14,182 | 15,047 | 11,231 |
| Accrued Expenses | 0 | 11,382 | 7,715 | 7,079 | 6,348 |
| TOTAL | $0 | $69,615 | $58,809 | $53,307 | $45,850 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 448 | 479 | 512 | 545 |
| TOTAL | $N/A | $2,237 | $2,123 | $2,502 | $2,151 |
| Total Liabilities | $0 | $71,852 | $60,932 | $55,809 | $48,001 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 55 | 55 | 55 | 55 |
| Other shareholders' equity | 0 | -6,128 | -6,274 | -6,421 | -6,493 |
| TOTAL | $0 | $7,690 | $7,465 | $7,195 | $6,934 |
| Total Liabilities And Equity | $0 | $79,542 | $68,397 | $63,004 | $54,935 |